Chemopreventive apigenin controls UVB-induced cutaneous proliferation and angiogenesis through HuR and thrombospondin-1
暂无分享,去创建一个
O. Volpert | J. Pelling | Xin Tong | S. Crawford | S. Mirzoeva | D. Veliceasa | Bryan Bridgeman | Philip S. Fitchev | Mona L. Cornwell
[1] A. Serafin,et al. Effects of potassium apigenin and verbena extract on the wound healing process of SKH‐1 mouse skin , 2014, International wound journal.
[2] R. Weinberg,et al. Thrombospondin-1 repression is mediated via distinct mechanisms in fibroblasts and epithelial cells , 2014, Oncogene.
[3] M. Gaestel,et al. The role of mammalian MAPK signaling in regulation of cytokine mRNA stability and translation. , 2014, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[4] S. Srikantan,et al. Tyrosine phosphorylation of HuR by JAK3 triggers dissociation and degradation of HuR target mRNAs , 2013, Nucleic acids research.
[5] H. Mukhtar,et al. MicroRNAs in skin response to UV radiation. , 2013, Current drug targets.
[6] J. Pelling,et al. Targeting the PI3K/Akt/mTOR axis by apigenin for cancer prevention. , 2013, Anti-cancer agents in medicinal chemistry.
[7] Jun Wang,et al. Multiple Functions of the RNA-Binding Protein HuR in Cancer Progression, Treatment Responses and Prognosis , 2013, International journal of molecular sciences.
[8] G. Halliday,et al. Non-melanoma skin cancer: carcinogenesis and chemoprevention , 2013, Pathology.
[9] T. Miki,et al. Apigenin Sensitizes Prostate Cancer Cells to Apo2L/TRAIL by Targeting Adenine Nucleotide Translocase-2 , 2013, PloS one.
[10] J. Keene,et al. Mechanisms coordinating ELAV/Hu mRNA regulons. , 2013, Current opinion in genetics & development.
[11] E. Y. Kim,et al. Sub-toxic dose of apigenin sensitizes HepG2 cells to TRAIL through ERK-dependent up-regulation of TRAIL receptor DR5 , 2013, Molecules and cells.
[12] A. Guialis,et al. HuR–hnRNP interactions and the effect of cellular stress , 2012, Molecular and Cellular Biochemistry.
[13] J. Henkin,et al. Prospective study of thrombospondin-1 mimetic peptides, ABT-510 and ABT-898, in dogs with soft tissue sarcoma. , 2012, Journal of veterinary internal medicine.
[14] R. Béliveau,et al. Diet-derived polyphenols inhibit angiogenesis by modulating the interleukin-6/STAT3 pathway. , 2012, Experimental cell research.
[15] V. Bours,et al. Casein kinase 2 inhibition modulates the DNA damage response but fails to radiosensitize malignant glioma cells. , 2012, International journal of oncology.
[16] C. Tayade,et al. Thrombospondin-1 mimetic peptide ABT-898 affects neovascularization and survival of human endometriotic lesions in a mouse model. , 2012, The American journal of pathology.
[17] K. Kajiya,et al. Ultraviolet light‐induced changes of lymphatic and blood vasculature in skin and their molecular mechanisms , 2012, Experimental dermatology.
[18] Sven Diederichs,et al. The hallmarks of cancer , 2012, RNA biology.
[19] J. Pelling,et al. Apigenin, a chemopreventive bioflavonoid, induces AMP‐activated protein kinase activation in human keratinocytes , 2012, Molecular carcinogenesis.
[20] O. Volpert,et al. Therapies using anti-angiogenic peptide mimetics of thrombospondin-1 , 2011, Expert opinion on therapeutic targets.
[21] J. Henkin,et al. ABT-898 Induces Tumor Regression and Prolongs Survival in a Mouse Model of Epithelial Ovarian Cancer , 2011, Molecular Cancer Therapeutics.
[22] D. Hanahan,et al. Hallmarks of Cancer: The Next Generation , 2011, Cell.
[23] J. Henkin,et al. A thrombospondin-mimetic peptide, ABT-898, suppresses angiogenesis and promotes follicular atresia in pre- and early-antral follicles in vivo. , 2010, Endocrinology.
[24] E. Ansó,et al. Flavonoids inhibit hypoxia-induced vascular endothelial growth factor expression by a HIF-1 independent mechanism. , 2010, Biochemical pharmacology.
[25] Laura E. Pascal,et al. Tumor suppressor U19/EAF2 regulates thrombospondin-1 expression via p53 , 2009, Oncogene.
[26] M. Weichenthal,et al. The angiogenesis inhibitor thrombospondin-1 inhibits acute cutaneous hypersensitivity reactions. , 2009, The Journal of investigative dermatology.
[27] S. Srikantan,et al. Post-transcriptional gene regulation by HuR promotes a more tumorigenic phenotype , 2008, Oncogene.
[28] J. Pelling,et al. Inhibition of HIF‐1 alpha and VEGF expression by the chemopreventive bioflavonoid apigenin is accompanied by Akt inhibition in human prostate carcinoma PC3‐M cells , 2008, Molecular carcinogenesis.
[29] J. Lawler,et al. Thrombospondins: from structure to therapeutics , 2008, Cellular and Molecular Life Sciences.
[30] B. Wienecke,et al. Apigenin‐induced nitric oxide production involves calcium‐activated potassium channels and is responsible for antiangiogenic effects , 2007, Journal of thrombosis and haemostasis : JTH.
[31] M. Resnick,et al. Blockade of beta-catenin signaling by plant flavonoid apigenin suppresses prostate carcinogenesis in TRAMP mice. , 2007, Cancer research.
[32] X. Hong,et al. Modulation of UVB‐induced and basal cyclooxygenase‐2 (COX‐2) expression by apigenin in mouse keratinocytes: Role of USF transcription factors , 2007, Molecular carcinogenesis.
[33] G. Chiou,et al. Apigenin inhibits laser-induced choroidal neovascularization and regulates endothelial cell function. , 2006, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.
[34] J. Pelling,et al. Apigenin Prevents UVB-Induced Cyclooxygenase 2 Expression: Coupled mRNA Stabilization and Translational Inhibition , 2006, Molecular and Cellular Biology.
[35] Xianglin Shi,et al. Apigenin inhibits tumor angiogenesis through decreasing HIF-1alpha and VEGF expression. , 2006, Carcinogenesis.
[36] A. Kong,et al. Modulation of activator protein-1 (AP-1) and MAPK pathway by flavonoids in human prostate cancer PC3 cells , 2006, Archives of pharmacal research.
[37] G. Boccaccio,et al. Mammalian Smaug Is a Translational Repressor That Forms Cytoplasmic Foci Similar to Stress Granules* , 2005, Journal of Biological Chemistry.
[38] X. Hong,et al. Inhibition of TPA‐induced cyclooxygenase‐2 (COX‐2) expression by apigenin through downregulation of Akt signal transduction in human keratinocytes , 2005, Molecular carcinogenesis.
[39] Xianglin Shi,et al. Apigenin Inhibits Expression of Vascular Endothelial Growth Factor and Angiogenesis in Human Lung Cancer Cells: Implication of Chemoprevention of Lung Cancer , 2005, Molecular Pharmacology.
[40] Bing-Hua Jiang,et al. Apigenin inhibits VEGF and HIF‐1 expression via PI3K/AKT/p70S6K1 and HDM2/p53 pathways , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[41] M. Detmar,et al. Ultraviolet B irradiation of human skin induces an angiogenic switch that is mediated by upregulation of vascular endothelial growth factor and by downregulation of thrombospondin‐1 , 2005, The British journal of dermatology.
[42] M. Detmar,et al. Tumor progression: the effects of thrombospondin-1 and -2. , 2004, The international journal of biochemistry & cell biology.
[43] G. T. Bowden,et al. UVA-mediated activation of signaling pathways involved in skin tumor promotion and progression. , 2004, Seminars in cancer biology.
[44] E. Rofstad,et al. Thrombospondin-1 treatment prevents growth of dormant lung micrometastases after surgical resection and curative radiation therapy of the primary tumor in human melanoma xenografts. , 2004, International journal of radiation oncology, biology, physics.
[45] Yue Xue,et al. The chemopreventive bioflavonoid apigenin modulates signal transduction pathways in keratinocyte and colon carcinoma cell lines. , 2003, The Journal of nutrition.
[46] P. Bornstein,et al. Restoration of thrombospondin 1 expression in tumor cells harbouring mutant ras oncogene by treatment with low doses of doxycycline. , 2003, Biochemical and biophysical research communications.
[47] Myoung H. Kim. Flavonoids inhibit VEGF/bFGF‐induced angiogenesis in vitro by inhibiting the matrix‐degrading proteases , 2003, Journal of cellular biochemistry.
[48] J. Redondo,et al. Cyclooxygenase-2: a therapeutic target in angiogenesis. , 2003, Trends in molecular medicine.
[49] M. Detmar,et al. Thrombospondin-1 selectively inhibits early-stage carcinogenesis and angiogenesis but not tumor lymphangiogenesis and lymphatic metastasis in transgenic mice , 2002, Oncogene.
[50] M. Detmar,et al. Targeted overexpression of the angiogenesis inhibitor thrombospondin-1 in the epidermis of transgenic mice prevents ultraviolet-B-induced angiogenesis and cutaneous photo-damage. , 2002, The Journal of investigative dermatology.
[51] J. Lawler,et al. Thrombospondin‐1 as an endogenous inhibitor of angiogenesis and tumor growth , 2002, Journal of cellular and molecular medicine.
[52] G. T. Bowden,et al. Role of p38 MAP kinases and ERK in mediating ultraviolet-B induced cyclooxygenase-2 gene expression in human keratinocytes , 2001, Oncogene.
[53] H. Inoue,et al. Roles of Akt and glycogen synthase kinase 3beta in the ultraviolet B induction of cyclooxygenase-2 transcription in human keratinocytes. , 2001, Cancer research.
[54] M. Detmar. The role of VEGF and thrombospondins in skin angiogenesis. , 2000, Journal of dermatological science.
[55] M. Detmar,et al. Thrombospondin‐1 suppresses wound healing and granulation tissue formation in the skin of transgenic mice , 2000, The EMBO journal.
[56] H. Xiao,et al. Increase in wild-type p53 stability and transactivational activity by the chemopreventive agent apigenin in keratinocytes. , 2000, Carcinogenesis.
[57] E. Fosslien. Biochemistry of Cyclooxygenase (COX)-2 Inhibitors and Molecular Pathology of COX-2 in Neoplasia , 2000, Critical reviews in clinical laboratory sciences.
[58] M. Skobe,et al. Overexpression of thrombospondin-1 decreases angiogenesis and inhibits the growth of human cutaneous squamous cell carcinomas. , 1999, The American journal of pathology.
[59] R. Hynes,et al. Thrombospondin-1 Is a Major Activator of TGF-β1 In Vivo , 1998, Cell.
[60] J. Pelling,et al. Induction of p21/WAF1 and G1 cell‐cycle arrest by the chemopreventive agent apigenin , 1997, Molecular carcinogenesis.
[61] P. Pour,et al. Inhibition of ultraviolet light induced skin carcinogenesis in SKH-1 mice by apigenin, a plant flavonoid. , 1997, Anticancer research.
[62] B. Li,et al. The chemopreventive flavonoid apigenin induces G2/M arrest in keratinocytes. , 1996, Carcinogenesis.
[63] D. Roberts,et al. Regulation of tumor growth and metastasis by thrombospondin‐1 , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[64] K. Dameron,et al. Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. , 1994, Science.
[65] M. L. Le Beau,et al. A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[66] W. Filipowicz,et al. Properties of the regulatory RNA-binding protein HuR and its role in controlling miRNA repression. , 2010, Advances in experimental medicine and biology.
[67] A. Bikfalvi,et al. Tumor angiogenesis , 2020, Advances in cancer research.
[68] O. Volpert,et al. The modulation of thrombospondin and other naturally occurring inhibitors of angiogenesis during tumor progression , 2004, Breast Cancer Research and Treatment.
[69] Tokichi Miyakawa,et al. Ultraviolet B-induced skin angiogenesis is associated with a switch in the balance of vascular endothelial growth factor and thrombospondin-1 expression. , 2004, The Journal of investigative dermatology.
[70] E. Fosslien. Molecular pathology of cyclooxygenase-2 in neoplasia. , 2000, Annals of clinical and laboratory science.
[71] R. Hynes,et al. Thrombospondin-1 is a major activator of TGF-beta1 in vivo. , 1998, Cell.
[72] J. Schelter,et al. Molecular and Cellular Pathobiology p 53-Responsive miR-194 Inhibits Thrombospondin-1 and Promotes Angiogenesis in Colon Cancers , 2011 .